CS logo
small CS logo
Sutter Cancer Centers Radiation Oncology Services-Cameron Park

Cameron Park, California, United States
Oncologist in Shingle Springs, California
3581 Palmer Dr #303, Shingle Springs, CA 95682

About Sutter Cancer Centers Radiation Oncology Services-Cameron Park


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Sutter Cancer Centers Radiation Oncology Services-Cameron Park


During the past decade, Sutter Cancer Centers Radiation Oncology Services-Cameron Park conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 64 clinical trials were completed, i.e. on average, 120.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 40 clinical trials were completed. i.e. 400% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer
2009-05-01
2010-05-01
Completed
15
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
2012-08-24
2022-05-31
Completed
717
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)
2012-12-03
2017-05-31
Terminated
182

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Sutter Cancer Centers Radiation Oncology Services-Cameron Park" #1 sponsor was "National Cancer Institute (NCI)" with 53 trials, followed by "Radiation Therapy Oncology Group" with 27 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Cancer Centers Radiation Oncology Services-Cameron Park" #1 collaborator was "National Cancer Institute (NCI)" with 81 trials as a collaborator, "NRG Oncology" with 45 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Sutter Cancer Centers Radiation Oncology Services-Cameron Park


According to Clinical.Site data, the most researched conditions in "Sutter Cancer Centers Radiation Oncology Services-Cameron Park" are "Prostate Cancer" (10 trials), "Head and Neck Cancer" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Recurrent Squamous Cell Lung Carcinoma" (6 trials). Many other conditions were trialed in "Sutter Cancer Centers Radiation Oncology Services-Cameron Park" in a lesser frequency.

Clinical Trials Intervention Types at Sutter Cancer Centers Radiation Oncology Services-Cameron Park


Most popular intervention types in "Sutter Cancer Centers Radiation Oncology Services-Cameron Park" are "Drug" (104 trials), "Other" (72 trials), "Radiation" (54 trials), "Biological" (50 trials) and "Procedure" (29 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (30 trials), "Paclitaxel" (18 trials), "Carboplatin" (16 trials) and "Cisplatin" (16 trials). Other intervention names were less common.

Clinical Trials Genders at Sutter Cancer Centers Radiation Oncology Services-Cameron Park


The vast majority of trials in "Sutter Cancer Centers Radiation Oncology Services-Cameron Park" are 93 trials for "All" genders, 30 trials for "Female" genders and 11 trials for "Male" genders.

Clinical Trials Status at Sutter Cancer Centers Radiation Oncology Services-Cameron Park


Currently, there are NaN active trials in "Sutter Cancer Centers Radiation Oncology Services-Cameron Park". undefined are not yet recruiting, 21 are recruiting, 66 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Sutter Cancer Centers Radiation Oncology Services-Cameron Park, 3 suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Sutter Cancer Centers Radiation Oncology Services-Cameron Park, 4 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status